• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Pulse rate variability predicted cardiovascular disease in sleep disordered breathing: The Guangdong sleep health study
CONCLUSIONS: PRV parameters may be specific predictors for CVD in SDB. PNN50 was a potent biomarker for CVD risk in the elderly with SDB, event without traditional CVD risk factors.PMID:37734671 | DOI:10.1016/j.rmed.2023.107408
Source: Respiratory Care - September 21, 2023 Category: Respiratory Medicine Authors: Miaochan Lao Qiong Ou Guangliang Shan Murui Zheng Guo Pei Yanxia Xu Longlong Wang Jiaoying Tan Bin Lu Source Type: research

Quantifying COPD as a risk factor for cardiac disease in a primary prevention cohort
Conclusions In a large real-world population without CVD, people with physician-diagnosed COPD were 25% more likely to have a major CVD event, after adjustment for CVD risk and other factors. This rate is comparable to the rate in people with diabetes and calls for more aggressive CVD primary prevention in the COPD population.
Source: European Respiratory Journal - August 31, 2023 Category: Respiratory Medicine Authors: Maclagan, L. C., Croxford, R., Chu, A., Sin, D. D., Udell, J. A., Lee, D. S., Austin, P. C., Gershon, A. S. Tags: COPD and smoking Original Articles: Tuberculosis and clinical trials Source Type: research

Chronic comorbid conditions and asthma exacerbation occurrence in a general population sample
In conclusion, several chronic comorbid conditions were associated with asthma exacerbation occurrence, which confirms but also complements previous studies. Our observations contribute to understanding exacerbation risk estimation and, ultimately, personalized asthma management.PMID:37567896 | DOI:10.1038/s41533-023-00350-x
Source: Respiratory Care - August 11, 2023 Category: Respiratory Medicine Authors: Emma Baljet Hilde Luijks Lisette van den Bemt Tjard R Schermer Source Type: research

Preserved Ratio Impaired Spirometry and Risks of Macrovascular, Microvascular Complications and Mortality Among Individuals With Type 2 Diabetes
Chest. 2023 Jun 17:S0012-3692(23)00794-8. doi: 10.1016/j.chest.2023.05.031. Online ahead of print.ABSTRACTBACKGROUND: The prospective associations of preserved ratio impaired spirometry (PRISm) with new-onset macrovascular and microvascular complications and mortality among individuals with type 2 diabetes (T2D) and whether PRISm enhances the prediction ability of an established office-based risk score remains to be elucidated.RESEARCH QUESTION: Can PRISm be used as a predictor of poor prognosis in individuals with T2D?STUDY DESIGN AND METHODS: We included 20,047 study participants with T2D and complete data on spirometry ...
Source: Chest - June 25, 2023 Category: Respiratory Medicine Authors: Guochen Li Matthew D Jankowich Luying Wu Yanqiang Lu Liping Shao Xujia Lu Yulong Fan Chen-Wei Pan Ying Wu Chaofu Ke Source Type: research

Association between REM-related mild obstructive sleep apnea and common cardiometabolic diseases
ConclusionCommon CMDs, particularly HT, tend to show an association with REM-OSA in patients with  mild OSA, but this association did not reach statistically significant levels.
Source: Sleep and Breathing - April 28, 2023 Category: Respiratory Medicine Source Type: research

Statement on Tobacco 21 from the European Respiratory Society Tobacco Control Committee
Tobacco consumption is the most significant cause of premature death across the European Union (EU) and is responsible for 700 000 deaths every year. Smokers are more likely than nonsmokers to develop lung cancer, COPD, coronary artery disease, stroke, diabetes, infertility and many other conditions [1]. According to Eurostat, 18.4% of people aged 15 years and over in the EU were daily smokers in 2019 [2]. Across Europe, the minimum age of sale of tobacco products is 18 years as per the obligations of the World Health Organization's Framework Convention on Tobacco Control (WHO FCTC).
Source: European Respiratory Journal - March 23, 2023 Category: Respiratory Medicine Authors: Cox, D. W., Rodriguez, L., Grigg, J., on behalf of the Tobacco Control Committee of the European Respiratory Society Tags: Editorials Source Type: research

COPD and COVID-19: a dangerous association?
Conclusion: COPDs patients are mostly ederly men with comorbidities. The most effective treatment for them was stabilization of comorbidities and conventional oxygen and for the most severe Helmet-CPAP and NIV. In addition, COPD patients had no higher risk of mortality from COVID-19 than individuals without a pre-existing diagnosis of COPD.
Source: European Respiratory Journal - December 1, 2022 Category: Respiratory Medicine Authors: Mendez Gonzalez, L., Ferreira, J., Caneiras, C. Tags: 05.02 - Monitoring airway disease Source Type: research

Comorbidities in patients with Obstructive Sleep Apnea syndrome (OSAS) in Reunion Island.
Conclusion: Morbid obesity, hypertension, diabetes, heart disease and respiratory illness are a predictor of severe OSAS in our patients especially snorers.
Source: European Respiratory Journal - December 1, 2022 Category: Respiratory Medicine Authors: Omarjee, B., Budhan, S., Kichenin, C., Omarjee, A., Vellin, J. F. Tags: 01.01 - Clinical problems - no related to asthma or COPD Source Type: research

Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe
Eur Respir Rev. 2022 Nov 2;31(166):220098. doi: 10.1183/16000617.0098-2022. Print 2022 Dec 31.ABSTRACTBACKGROUND: As mortality from coronavirus disease 2019 (COVID-19) is strongly age-dependent, we aimed to identify population subgroups at an elevated risk for adverse outcomes from COVID-19 using age-/gender-adjusted data from European cohort studies with the aim to identify populations that could potentially benefit from booster vaccinations.METHODS: We performed a systematic literature review and meta-analysis to investigate the role of underlying medical conditions as prognostic factors for adverse outcomes due to sever...
Source: Respiratory Care - November 2, 2022 Category: Respiratory Medicine Authors: Constantine I Vardavas Alexander G Mathioudakis Katerina Nikitara Kimon Stamatelopoulos Georgios Georgiopoulos Revati Phalkey Jo Leonardi-Bee Esteve Fernandez Dolors Carnicer-Pont J ørgen Vestbo Jan C Semenza Charlotte Deogan Jonathan E Suk Piotr Kramarz Source Type: research

Study on the predictive ability of emergency CHADS < sub > 2 < /sub > score and CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc score for coronary artery disease and prognosis in patients with acute ST-segment elevation myocardial infarction
CONCLUSIONS: Multiple factors jointly affect the severity and prognosis of CAD in patients with acute STEMI. The CHA2DS2-VASc score is better than the CHADS2 score in predicting the severity of coronary artery lesions and prognosis of patients, providing theoretical support for clinical practice.PMID:35928606 | PMC:PMC9344425 | DOI:10.21037/jtd-22-763
Source: Journal of Thoracic Disease - August 5, 2022 Category: Respiratory Medicine Authors: Xin Huang Hong Lv Zeyan Liu Yuan Liu Xue Yang Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10